Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Argus Health
Mallinckrodt
Novartis
Farmers Insurance
Deloitte
Citi
Chinese Patent Office
Cerilliant
Queensland Health

Generated: February 24, 2018

DrugPatentWatch Database Preview

NUPRIN Drug Profile

« Back to Dashboard

When do Nuprin patents expire, and when can generic versions of Nuprin launch?

Nuprin is a drug marketed by Bristol Myers and J And J Consumer Inc and is included in three NDAs.

The generic ingredient in NUPRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-one suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

US Patents and Regulatory Information for NUPRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers NUPRIN ibuprofen TABLET;ORAL 072035-001 Feb 16, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc NUPRIN ibuprofen TABLET;ORAL 019012-002 Jul 29, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers NUPRIN ibuprofen TABLET;ORAL 072036-001 Feb 16, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc NUPRIN ibuprofen TABLET;ORAL 019012-001 May 18, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Merck
Daiichi Sankyo
Cantor Fitzgerald
Harvard Business School
Cerilliant
QuintilesIMS
Chinese Patent Office
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot